Clinical trial
A Single-blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks
NCT00206765 is registered in ClinicalTrials.gov with Beth Israel Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks
- Lead sponsor
- Beth Israel Medical Center
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- January 31, 2003
- Completion date
- July 31, 2005
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
major depressive disorder with panic attacks, panic disorder